Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009

Administered by Department of Veterans' Affairs

Legislation au F2009L01588 Not in force Legislative Instrument

Legislation content

Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009

made under subsection 196B(2) of the

Veterans' Entitlements Act 1986

Compilation No. 2  

Compilation date:   18 September 2017

Includes amendments up to: Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017 (No. 58 of 2017) (F2017L01067)

The day of commencement of this Amendment Determination is 18 September 2017.

 

About this compilation

 

This compilation

This is a compilation of the Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009 that shows the text of the law as amended and in force on 18 September 2017.

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Selfrepealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

 

 

 

 

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE CEREBRAL MENINGES

No. 21 of 2009

 

for the purposes of the

 

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

 

Title

1. This Instrument may be cited as Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009.

 

Determination

2. The Repatriation Medical Authority under subsection 196B(2) and (8) of the Veterans’ Entitlements Act 1986 (the VEA):

(a) revokes Instrument No. 205 of 1995 concerning malignant neoplasm of the cerebral meninges; and

(b) determines in its place this Statement of Principles.

 

Kind of injury, disease or death

3. (a) This Statement of Principles is about malignant neoplasm of the cerebral meninges and death from malignant neoplasm of the cerebral meninges.

(b)               For the purposes of this Statement of Principles, "malignant neoplasm of the cerebral meninges" means a primary malignant neoplasm arising from the cells of the cerebral meninges.  This definition excludes soft tissue sarcoma, carcinoid tumour, non-Hodgkin's lymphoma, Hodgkin's lymphoma and melanoma.

(c)                Malignant neoplasm of the cerebral meninges attracts ICD-10-AM code C70.0 or C70.9.

(d)              In the application of this Statement of Principles, the definition of "malignant neoplasm of the cerebral meninges" is that given at paragraph 3(b) above.

 

Basis for determining the factors

4. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the cerebral meninges and death from malignant neoplasm of the cerebral meninges can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the Military Rehabilitation and Compensation Act 2004 (the MRCA).

 

Factors that must be related to service

5. Subject to clause 7, at least one of the factors set out in clause 6 must be related to the relevant service rendered by the person.

 

Factors

6. The factor that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the cerebral meninges or death from malignant neoplasm of the cerebral meninges with the circumstances of a person’s relevant service is:

 

(a)                having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the brain at least five years before the clinical onset of malignant neoplasm of the cerebral meninges; or

 

(b)               inability to obtain appropriate clinical management for malignant neoplasm of the cerebral meninges.

 

Factors that apply only to material contribution or aggravation

7. Paragraph 6(b) applies only to material contribution to, or aggravation of, malignant neoplasm of the cerebral meninges where the person’s malignant neoplasm of the cerebral meninges was suffered or contracted before or during (but not arising out of) the person’s relevant service.

 

Inclusion of Statements of Principles

8. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

 

Other definitions

9. For the purposes of this Statement of Principles:

"cumulative equivalent dose" means the total dose of ionising radiation received by the particular organ or tissue from external exposure, internal exposure or both, apart from normal background radiation exposure in Australia, calculated in accordance with the methodology set out in Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017;

Note 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.

Note 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.

 

"death from malignant neoplasm of the cerebral meninges" in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the cerebral meninges;

 

"ICD-10-AM code" means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), Sixth Edition, effective date of 1 July 2008, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 978 1 74210 016 6;

 

"relevant service" means:

(a) operational service under the VEA;

(b) peacekeeping service under the VEA;

(c)                hazardous service under the VEA;

(d)               warlike service under the MRCA; or

(e)                non-warlike service under the MRCA;

 

"terminal event" means the proximate or ultimate cause of death and includes:

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e)                cessation of brain function.

 

Application

10. This Instrument applies to all matters to which section 120A of the VEA or section 338 of the MRCA applies.

 

Date of effect

11. This Instrument takes effect from 6 May 2009.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history. 

Endnote 2—Abbreviation key

 

o = order(s)

ad = added or inserted

Ord = Ordinance

am = amended

orig = original

amdt = amendment

par = paragraph(s)/subparagraph(s)

c = clause(s)

    /subsubparagraph(s)

C[x] = Compilation No. x

pres = present

Ch = Chapter(s)

prev = previous

def = definition(s)

(prev…) = previously

Dict = Dictionary

Pt = Part(s)

disallowed = disallowed by Parliament

r = regulation(s)/rule(s)

Div = Division(s)

 

exp = expires/expired or ceases/ceased to have

reloc = relocated

    effect

renum = renumbered

F = Federal Register of Legislation

rep = repealed

gaz = gazette

rs = repealed and substituted

LA = Legislation Act 2003

s = section(s)/subsection(s)

LIA = Legislative Instruments Act 2003

Sch = Schedule(s)

(md) = misdescribed amendment can be given

Sdiv = Subdivision(s)

    effect

SLI = Select Legislative Instrument

(md not incorp) = misdescribed amendment

SR = Statutory Rules

    cannot be given effect

SubCh = SubChapter(s)

mod = modified/modification

SubPt = Subpart(s)

No. = Number(s)

underlining = whole or part not

 

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009

 

1 May 2009

 

F2009L01588

6 May 2009

 

 

Amendment Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 57 of 2011

 

18 May 2011

 

F2011L00798

 

25 May 2011

 

 

Veterans' Entitlements (Statements of Principles—Cumulative Equivalent Dose) Amendment Determination 2017 (No. 58 of 2017)

 

22 August 2017

 

F2017L01067

 

18 September 2017

 

 

 

Endnote 4—Amendment history

 

Provision affected

How affected

Clause 6(a)……………..

rs. Instrument  No. 57 of 2011

Clause 6(b)……………..

rep. Instrument No. 57 of 2011

Clause 6(c)……………..

am. Instrument  No. 57 of 2011

Clause 7 – '6(c)………..'

am. Instrument No. 57 of 2011

Clause 9 – ' "cumulative equivalent dose"…'

rs. Instrument No. 57 of 2011

Clause 9 – ' "a course of therapeutic radiation"…………….'

rep. Instrument No. 57 of 2011

Clause 9 – ' "atomic radiation"…………….'

rep. Instrument No. 57 of 2011

Clause 9 – ' "cumulative equivalent dose"……'

rs. Instrument  No. 58 of 2017

 

 

Overview

The Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009 is a legislative instrument made under subsection 196B(2) of the Veterans' Entitlements Act 1986. This Statement of Principles addresses the issue of malignant neoplasm of the cerebral meninges and death from such neoplasm in veterans, members of Peacekeeping Forces, or members of the Forces, as well as members under the Military Rehabilitation and Compensation Act 2004. The Repatriation Medical Authority, acting under the authority of the Act, determined this Statement of Principles to provide clarity on the conditions and factors related to malignant neoplasm of the cerebral meninges that may be considered in relation to relevant military service. The policy objective behind this legislation is to ensure that veterans and their families receive appropriate recognition and compensation for service-related conditions, thereby fulfilling the Commonwealth's moral obligation to those who have served.

Scope and Application

The Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009, made under the Veterans' Entitlements Act 1986 and Military Rehabilitation and Compensation Act 2004, applies to matters concerning veterans, members of Peacekeeping Forces, or members of the Australian Defence Force, as well as those covered under the Military Rehabilitation and Compensation Act 2004. The Act is specifically focused on malignant neoplasm of the cerebral meninges and death resulting from this condition. It outlines the conditions under which these medical conditions can be linked to service, primarily through the receipt of a cumulative equivalent dose of ionising radiation to the brain at least five years prior to the onset of the condition or the inability to obtain appropriate clinical management. The Statement of Principles revokes the previous Instrument No. 205 of 1995 and sets out a new framework for determining the relationship between service and malignant neoplasm of the cerebral meninges. The instrument takes effect from 6 May 2009 and has been amended to incorporate changes such as the definition of "cumulative equivalent dose" and the methodology for its calculation, as well as other adjustments to terminology and application criteria.

Key Provisions

The Statement of Principles concerning malignant neoplasm of the cerebral meninges No. 21 of 2009, as made under subsection 196B(2) of the Veterans' Entitlements Act 1986, sets out the legislative provisions regarding the recognition of malignant neoplasm of the cerebral meninges in veterans, members of Peacekeeping Forces, and members of the Forces under the Veterans' Entitlements Act 1986 (VEA), or members under the Military Rehabilitation and Compensation Act 2004 (MRCA). This Statement of Principles revokes the previous Instrument No. 205 of 1995 and replaces it with the current provisions. The document specifies that malignant neoplasm of the cerebral meninges refers to a primary malignant neoplasm arising from the cells of the cerebral meninges, excluding certain other types of neoplasms such as soft tissue sarcoma, carcinoid tumour, non-Hodgkin's lymphoma, Hodgkin's lymphoma, and melanoma. It also indicates that this type of neoplasm is classified under ICD-10-AM codes C70.0 or C70.9. The Repatriation Medical Authority has determined that there is sound medical-scientific evidence linking malignant neoplasm of the cerebral meninges and death from such neoplasms to relevant service rendered by the individuals covered under the VEA or MRCA. To establish a connection between the malignant neoplasm of the cerebral meninges and the relevant service, at least one of the factors set out in clause 6 must be related to the service. These factors include receiving a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the brain at least five years before the onset of the neoplasm, or an inability to obtain appropriate clinical management for the condition. Notably, the factor regarding the inability to obtain appropriate clinical management applies only to cases of material contribution to, or aggravation of, the neoplasm if it was suffered or contracted before or during (but not arising out of) the relevant service. Additionally, this Statement of Principles includes other definitions pertinent to its application, such as 'cumulative equivalent dose', which is the total dose of ionising radiation received by the brain apart from normal background radiation exposure in Australia, calculated according to specific methodology. Other terms defined include 'death from malignant neoplasm of the cerebral meninges', 'ICD-10-AM code', 'relevant service', and 'terminal event'. The Statement of Principles applies to all matters to which section 120A of the VEA or section 338 of the MRCA applies and took effect from 6 May 2009. The Statement of Principles imposes certain obligations on the parties it governs. Specifically, it requires that at least one of the stipulated factors must be related to the relevant service to establish a connection between the malignant neoplasm of the cerebral meninges and the service. This includes ensuring that the cumulative equivalent dose of ionising radiation to the brain is at least 0.1 sievert if it was received at least five years before the onset of the neoplasm or that there was an inability to obtain appropriate clinical management for the condition. These obligations are designed to ensure that the criteria for recognition and compensation are met according to the medical-scientific evidence. Failure to comply with the provisions of this Statement of Principles may have civil or administrative consequences, particularly in the context of claims for veterans' entitlements or military rehabilitation and compensation. However, the Statement of Principles itself does not explicitly outline specific offences, penalties, or consequences for breach. The consequences of non-compliance would typically be addressed in the broader legislative framework of the VEA and MRCA, which may include the denial of entitlements or compensation claims if the stipulated factors are not met or properly substantiated.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Offence Provisions
Licensing & Registration
Catchwords
Cumulative Equivalent Dose

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.